The transmembrane protein-tyrosine phosphatase (PTP) DEP-1 (density-enhanced phosphatase) is a candidate tumor suppressor in the colon epithelium. We have explored the function of DEP-1 in colon epithelial cells by inducible re-expression in a DEP-1-deficient human colon cancer cell line. Density-enhanced phosphatase-1 reexpression led to profound inhibition of cell proliferation and cell migration, and was associated with cytoskeletal rearrangements. These effects were dependent on the PTP activity of DEP-1 as they were not observed with cells expressing the catalytically inactive DEP-1 C1239S variant. shRNA-mediated suppression of DEP-1 in a colon epithelial cell line with high endogenous DEP-1 levels enhanced proliferation, further supporting the antiproliferative function of DEP-1. Nutrients, which are considered to be chemoprotective with respect to colon cancer development, including butyrate, green tea and apple polyphenols, had the capacity to elevate transcription of endogenous DEP-1 mRNA and expression of DEP-1 protein. Upregulation of DEP-1 expression, and in turn inhibition of cell growth and migration may present a previously unrecognized mechanism of chemoprevention by nutrients.
DEP-1 (high cell density-enhanced phosphatase-1, also designated CD148, PTPRJ) (Ö stman et al., 1994) , encoded by the PTPRJ gene, is a class III transmembrane protein-tyrosine phosphatase (PTP) that contains a single PTP domain. Several lines of evidence suggest that DEP-1 represents a tumor suppressor protein. In mammary carcinoma, thyroid carcinoma, glioma and pancreatic carcinoma cell lines, DEP-1 overexpression resulted in potent antitransforming effects (Keane et al., 1996; Trapasso et al., 2000 Trapasso et al., , 2004 Iuliano et al., 2003; Massa et al., 2004) . Density-enhanced phosphatase-1 has been shown to negatively regulate signaling of receptor tyrosine kinases, including the platelet-derived growth factor receptor, VEGFR-2 and c-Met (Kovalenko et al., 2000; Jandt et al., 2003; Lampugnani et al., 2003; Palka et al., 2003; Kellie et al., 2004) . The capacity of DEP-1 to antagonize signaling of these tyrosine kinases may relate to its antitransforming activity. Furthermore, the locus Scc-1, which has been linked with susceptibility to colon cancer in mice, harbors the PTPRJ gene (Ruivenkamp et al., 2002) . Loss of heterozygosity for DEP-1 has previously been described in about 71% (25 of 35) cases of colon carcinoma and 47% (22 of 47) of colon adenoma samples (Ruivenkamp et al., 2003) .
Little is known about DEP-1 expression in colon carcinoma at the protein level. We therefore, analysed a panel of colon cell lines for DEP-1 protein expression. As shown in Figure 1a , expression in the analysed cell lines varies from relatively high levels in LT 97 adenoma cells and HT 29, DLD-1, HCT-16, COGA-1 and COGA-12 colon carcinoma cells, to relatively low levels in LOVO, Colo-320, COGA-2 and COGA-3 cells, and no detectable DEP-1 protein expression in SW 480 cells. To analyse the functional effects of DEP-1 expression, we chose the DEP-1-negative SW 480 cell line to reexpress the PTP. cDNA encoding wild-type human DEP-1, or the catalytically inactive DEP-1 C1239S was transferred into the bicistronic, tetracycline-regulated (tet-off) expression vector pNRTIS21 (Tenev et al., 2000) . SW 480 cells were transfected with the corresponding constructs, and resistant cell clones were selected and screened for inducible DEP-1 expression. In selected cell clones, expression of DEP-1 wild-type or the DEP-1 CS mutant to comparable levels occurred in the absence of anhydrotetracylin (ATC), whereas only very low levels of DEP-1 protein were detectable in its presence (Figure 1b) .
These cell lines were analysed for biological effects of DEP-1 re-expression. Cell proliferation in presence of wild-type DEP-1 was clearly reduced as compared to cells with suppressed DEP-1 expression (Figure 2a ). Inducible expression of the catalytically inactive DEP-1 CS variant had, however, no effect on proliferation (Figure 2b ), establishing that DEP-1 PTP activity is required for the antiproliferative effect. In addition, we generated derivatives of HT 29 cells, a cell line with high endogenous DEP-1 levels (Figure 1a) , by retroviral transduction with a shRNA, which efficiently downregulates DEP-1 expression (Figure 1c) . HT 29 cells with suppressed DEP-1 expression had a growth advantage compared to corresponding control cells, particularly under conditions of reduced serum (Figure 2c ), confirming the antiproliferative function of this PTP. Antiproliferative activity of DEP-1 has previously been reported in breast cancer, thyroid cancer and glioma cells lines (Keane et al., 1996; Iuliano et al., 2003; Massa et al., 2004) , as well as in vascular cells (Lampugnani et al., 2003; Takahashi et al., 2003) . Our data clearly show that DEP-1 has an antiproliferative potential in colon epithelial cells. . LT 97, a human colon adenoma cell line, was a kind gift from Prof Brigitte Marian (Institute for Cancer Research, University of Vienna, Austria) and was maintained as previously described (Richter et al., 2002) . The other cell lines were obtained from DSMZ (Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH, Braunschweig). All cell lines were grown to confluence, and lysates from a 75 cm 2 flask each were subjected to DEP-1 immunoprecipitation and immunoblotting as described previously (Jandt et al., 2003) . Lysate aliquots were subjected to immunoblotting for actin to compare inputs. (b) DNAs encoding wild-type DEP-1 and the DEP-1 C1239S mutant were subcloned from previously described plasmids (Jandt et al., 2003) into the EcoRI restriction site of the vector pNRTIS21 (Tenev et al., 2000) . The constructs were linearized with Bst Z171 and then transfected using Lipofectamine 2000 (Invitrogen GmbH, Karlsruhe). G418 resistant (100 mg/ml) cell clones were obtained in the presence of anhydrotetracylin (ATC, 100 ng/ml) and analysed for DEP-1 expression in absence (À) or presence ( þ ) of ATC as in (a). Detection of total Erk1/2 was used as a loading control. (c) Suppression of endogenous DEP-1 in HT29 cells by shRNA. A previously published siRNA sequence (Lampugnani et al., 2003) was used to generate a corresponding shRNA construct in the vector pSUPER.retro.puro (Oligoengine) according to the instructions of the manufacturer. Stable cell pools were generated by retroviral transduction using the DEP-1 targeting shRNA (targ), or a corresponding non-targeting construct (nt). The efficiency of DEP-1 protein suppression is shown by immunoblotting. (d) and (e), except that 10 mM LPA was used as the motogen (mean values7s.d., ***Po0.001). (i) Effect of DEP-1 re-expression on actin cytoskeleton. Cells were seeded on top of collagen-coated coverslips and stained with anti-DEP-1 antibodies (0.5 mg/ml at RT for 1 h, followed by DTAF-labeled antimouse-IgG (Jackson Immunoresearch Laboratories, USA), 1:50 in PBS at room temperature (RT) for 1 h; green channel), TRITC-labeled phalloidin for staining of actin (1 mM at RT for 2 h; red channel), and 4 0 6-diamidino-2-phenylindole-2HCl to visualize nuclei (2 mg/ml for 5 min; blue channel). Pictures were taken with a Zeiss AxioCam HRC digital camera system, mounted on a Zeiss Axioplan2 microscope, and the Axio Vision 3.1 software. Upper panel: cells that do not express DEP-1. Lower panel: cells expressing wild-type DEP-1. Note the increased size and flattened morphology upon DEP-1 expression.
We further subjected the DEP-1 re-expressing SW 480 cells to cell migration assays. In wounding assays in the presence of fetal calf serum (FCS), DEP-1 wild-type expression led to a clear reduction in cell migration, whereas the DEP-1 CS mutant had no effect (Figure  3a-c) . Inhibition of cell migration, thus, also depends on DEP-1 PTP activity. Wounding assays were performed over 24 h, and cell proliferation is likely to contribute to repopulation of the wound. To exclude proliferation effects, we therefore conducted also migration assays with a modified Boyden chamber system. Consistent with the results in the wounding assays, wild-type DEP-1 expression significantly reduced migration toward FCS (Figure 3d ), whereas DEP-1 CS had no effect on it Figure 3e ). To explore whether the inhibitory effect of DEP-1 depends on the motogen, we also tested the effect of DEP-1 expression on migration in serum-free medium in the presence of lysophosphatidic acid (LPA). LPA effectively stimulated cell migration in this assay nearly as efficiently as FCS (Figure 3f ). Densityenhanced phosphatase-1 wild-type expression inhibited also migration in the presence of LPA (Figure 3g and h ). This finding may indicate the existence of common cellular targets for DEP-1 downstream of different receptors that transduce motogenic signals. Density-enhanced phosphatase-1-expressing cells are flattened and exhibit a different distribution of filamentous actin, typically characterized by cortical actin bundles near to the cell periphery (Figure 3i ). Cytoskeletal rearrangements upon DEP-1 expression have previously been described in DEP-1-overexpressing fibroblasts (Kellie et al., 2004) , and may be associated with the observed attenuation of cell migration. The targets of DEP-1, which are responsible for these phenotypic changes, are as yet unknown. A DEP-1-mediated modulation of Src-family kinase activity, as observed in fibroblasts (Jandt et al., 2003) and thyroid carcinoma cells (Le Pera et al., 2005) , may contribute to actin reorganization. Candidate signaling mechanisms that might be affected in the DEP-1 re-expressing SW 480 cells are currently under investigation.
Normal epithelial cells in the colon are constantly exposed to dietary components and their fermentation products, such as butyrate. A number of food ingredients and their metabolites have protective functions with respect to colon cancer development, yet the underlying mechanisms are only partially characterized. Notably, apple intake has a strong antiproliferative effect on carcinogen-induced lesions in animals, and in cancer cells in culture (Barth et al., 2005; Gosse et al., 2005) . Another interesting compound of dietary origin is butyrate. Butyrate is produced in the colon as fermentation product from various precursors. It is known for its antiproliferative activity on colon cancer cells in which it also induces apoptosis, whereas it also acts as a survival factor and a nutrient in non-transformed cells (PoolZobel et al., 2005b) and references therein). Butyrate has earlier been shown to enhance DEP-1 expression and to induce differentiation in mammary carcinoma cell lines (Keane et al., 1996) . Epigallocatechine-3-gallate (EGCG), a major component of green tea, and related constituents have various anticancer effects, including Figure 4 Effect of protective nutrients on density-enhanced phosphatase (DEP)-1 expression in colon epithelial cells. (a) A freezedried polyphenol extract from a mixture of table apples was generated as described earlier (Barth et al., 2005) , and kindly provided by Dr F Will (Research Institute Geisenheim, Germany). For cell treatments, the lyophilisate was freshly dissolved in medium and sterilefiltered. A green tea extract (GTE) was kindly provided by Kampffmeyer Food Service GmbH (Hamburg, Germany). Preparation of a GTE-standard as well as its composition have been described (Glei et al., 2003) . Subconfluent cultures of HT 29 and CaCo2 cells were left untreated (control, C), or were treated for 72 h with 2 mM sodium butyrate (But), apple polyphenol extract (AE) at a concentration equivalent to 25 mM phloridzin, or GTE at a concentration equivalent to 20 mM epigallocatechine-3-gallate. Density-enhanced phosphatase-1 expression was analysed as described in the legend to inhibition of proliferation of human colon cancer cells (Kautenburger et al., 2006; Shimizu et al., 2005) .
We considered the intriguing possibility that such nutrient components may modulate DEP-1 expression and thereby exert protective functions in the colon. Treatment with butyrate and green tea extract (GTE) resulted in enhanced expression of DEP-1 in HT 29 and CaCo2 cells (Figure 4a ), whereas apple polyphenols failed to modulate DEP-1 expression in these carcinoma lines. However, in LT 97 adenoma cells, the apple polyphenol extract enhanced expression of DEP-1 clearly in a dose-dependent fashion (Figure 4b) . Thus, these nutrients may exert a protective role with respect to colon carcinogenesis by upregulating DEP-1. The induction of DEP-1 cannot be attributed to increases in cell density, as all dietary components either inhibited cell growth (butyrate, apple polyphenols) or had little influence on cell proliferation (GTE). We observed an induction of DEP-1 mRNA in LT97 adenoma cells by all three tested nutrient components to a similar extent as observed at the protein level (Figure 4c ). This finding suggests that transcriptional regulation is, at least in part, the underlying mechanism of DEP-1 induction and is in line with current concepts for protective nutrient activity (Pool-Zobel et al., 2005a) . DEP-1 induction by nutrients may additionally involve effects at the protein level, such as on protein stability. Induction of DEP-1 is, however, not the only mechanism of growth inhibition by butyrate or apple polyphenols, as shRNA-mediated depletion of DEP-1 did not render HT 29 cells refractory to growth inhibition by these agents (not shown). To our knowledge, this is the first report where the effects of protective nutrients are attributed to the upregulation of a tumor suppressor. This suggests an upregulation of DEP-1 as a previously unrecognized aspect of chemoprevention by dietary compounds.
